ET
VCYT icon

Entropy Technologies’s Veracyte VCYT Stock Holding History

Entropy Technologies’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,500
Closed -$257K – 1109
2025
Q2 		$257K Buy
+9,500
New +$275K 0.02% 652
2024
Q4 		– Sell
-12,836
Closed -$437K – 1013
2024
Q3 		$437K Buy
+12,836
New +$361K 0.05% 470

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Entropy Technologies's VCYT Position: Q3 2025 in Review

Entropy Technologies sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 9,500 shares — an estimated $257K sold.

Entropy Technologies first reported a position in VCYT in Q3 2024 and held it in 2 quarters. The position peaked at $437K in Q3 2024. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Entropy Technologies reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Entropy Technologies sold 9,500 Veracyte shares in Q3 2025, an estimated $257K.
  • Entropy Technologies first reported a position in Veracyte in Q3 2024 and held it in 2 quarters.
  • Entropy Technologies's Veracyte position peaked at $437K in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Entropy Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.